secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRADIMED CORP (IRMD)
CIK:        0001325618
Form:       8-K
Filed at:   2021-11-23T23:59:59+00:00
Accession:  0000898432-21-000732
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

CEO Roger Susi enters new 10b5-1 plan to sell shares over 12 months
-------------------------------------------------------------------

- Plan replaces prior June 2021 plan; allows daily sales from Nov 22, 2021 to Nov 21, 2022.
- Sales subject to minimum market price threshold; executed shares disclosed via Form 4 filings.
- Purpose: increase public float in a non-dilutive manner.
- Plan terminates on earlier of Nov 21, 2022, full execution, or termination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1325618/000089843221000732/0000898432-21-000732-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1325618/000089843221000732/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0000898432-21-000732

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer